Abstract:Graphical and Lay Summary CRISPR/Cas9 technology combined with somatic cell nuclear transfer (SCNT) provides the primary method for producing gene‐edited pigs, with high‐quality gene‐edited nuclear donors closely associated with the forms of CRISPR/Cas9. The authors developed a platform based on fluorescence reporting signals and micropattern arrays to visually assess the efficiency of gene editing. It was efficiently determined that mRNA form targeting porcine cells had the highest editing efficiency. This platform also holds great potential for rapidly testing new gene editing tools, evaluating delivery methods, and customizing assessment platforms for various cell types. CRISPR/Cas9 technology, combined with somatic cell nuclear transplantation (SCNT), represents the primary approach to generating gene‐edited pigs. The inefficiency in acquiring gene‐edited nuclear donors is attributed to low editing and delivery efficiency, both closely linked to the selection of CRISPR/Cas9 forms. However, there is currently no direct method to evaluate the efficiency of CRISPR/Cas9 editing in porcine genomes. A platform based on fluorescence reporting signals and micropattern arrays was developed in this study, to visually assess the efficiency of gene editing. The optimal specifications for culturing porcine cells, determined by the quantity and state of cells grown on micropattern arrays, were a diameter of 200 μm and a spacing of 150 μm. By visualizing the area of fluorescence loss and measuring the gray value of the micropattern arrays, it was quickly determined that the mRNA form targeting porcine cells exhibited the highest editing efficiency compared to DNA and Ribonucleoprotein (RNP) forms of CRISPR/Cas9. Subsequently, four homozygotes of the β4GalNT2 gene knockout were successfully obtained through the mRNA form, laying the groundwork for the subsequent generation of gene‐edited pigs. This platform facilitates a quick, simple, and effective evaluation of gene knockout efficiency. Additionally, it holds significant potential for swiftly testing novel gene editing tools, assessing delivery methods, and tailoring evaluation platforms for various cell types.

Efficient CRISPR/Cas9-mediated gene editing in mammalian cells by the novel selectable traffic light reporters

SgRNA Engineering for Improved Genome Editing and Expanded Functional Assays.

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

A Universal Surrogate Reporter for Efficient Enrichment of CRISPR/Cas9-Mediated Homology-Directed Repair in Mammalian Cells.

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Enrichment of Prime-Edited Mammalian Cells with Surrogate PuroR Reporters

Highly Efficient and Rapid Detection of the Cleavage Activity of Cas9/gRNA Via a Fluorescent Reporter

High‐efficiency and multilocus targeted integration in CHO cells using CRISPR‐mediated donor nicking and DNA repair inhibitors

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Dual-reporter Surrogate Systems for Efficient Enrichment of Genetically Modified Cells

A Surrogate Reporter System for Multiplexable Evaluation of CRISPR/Cas9 in Targeted Mutagenesis

A novel sgRNA selection system for CRISPR-Cas9 in mammalian cells

Small molecules enhance CRISPR genome editing in pluripotent stem cells

A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines

Visual screening of CRISPR/Cas9 editing efficiency based on micropattern arrays for editing porcine cells

Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening

Reporter Mice for Gene Editing: A Key Tool for Advancing Gene Therapy of Rare Diseases

High-content imaging-based pooled CRISPR screens in mammalian cells

Development of a universal antibiotic resistance screening system for efficient enrichment of C-to-G and A-to-G base editing

Verification of CRISPR/Cas9 Activity In Vitro via SSA-Based Dual-Luciferase Reporter System

Enhanced CRISPR/Cas9-mediated Biallelic Genome Targeting with Dual Surrogate Reporter-Integrated Donors.